Nearly 400,000 people worldwide are known to have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) beginning in December 2019. The virus …

In the race to contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
efficient detection and triage of infected patients must rely on rapid and reliable testing. In …

A reliable diagnostic assay is crucial to early detect new COVID-19 cases and limit severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Since the onset of …

The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly
implement and validate diagnostic assays and to expand testing capacity in a short …

Analytical sensitivity for SARS-CoV-2 detection is a key performance metric for the
evaluation of viral detection assays. We determined analytical limits of detection for seven …

Multiple laboratory-developed tests (LDTs) and commercially available assays have
emerged to meet diagnostic needs related to the severe acute respiratory syndrome …

Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …

Background High-throughput assays for the SARS-CoV-2 virus are critical to increasing test
capacity and slowing the spread of COVID-19. Abbott Molecular developed and received …

In December 2019, a novel coronavirus (SARS-CoV-2) was first isolated from Wuhan city,
China and within three months, the global community was challenged with a devastating …

Background The recent emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has resulted in a rapid proliferation of serologic assays. However, little is …